LONA SWINEY: Open Payments
NPI 1346689619 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 77 payments from 19 companies in 2025. Trend: 2023 $888 · 2024 $1,444 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $311 |
| ABBVIE INC. | 18 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Abbott Laboratories | 3 | $51 |
| PFIZER INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
Products named: CAPLYTA, Kerendia, Rybelsus, Ozempic, Wegovy, QULIPTA, VRAYLAR, Auvelity.
Industry payments across VA — which companies pay providers there.
